Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2016

Publisher Name :
Date: 27-Sep-2016
No. of pages: 128
Inquire Before Buying

Notes:

Sales, means the sales volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Revenue, means the sales value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

This report studies sales (consumption) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Conatus Pharmaceuticals

- Daewoong Pharmaceutical

- Galmed International

- Kyorin Pharmaceutical

- Metabolic Solutions Development

- Novartis AG

- Phenex Pharmaceuticals

- Raptor Pharmaceuticals

- TCM Biotech International

- Tobira Therapeutics

- Verva Pharmaceuticals

- Zafgen

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2016

Table of Contents
Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2016
1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2011-2021)
1.5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2021)
1.5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Competition by Manufacturers, Type and Application
2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
2.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2011-2016)
2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type
2.2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2011-2016)
2.2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2011-2016)
2.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Regions
2.3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2011-2016)
2.3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2011-2016)
2.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application
3 USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
3.1 USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
3.1.1 USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
3.1.2 USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
3.1.3 USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
3.2 USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
3.3 USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
3.4 USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
4.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
4.1.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
4.1.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
4.1.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
4.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
4.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
4.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
5 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
5.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
5.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
5.1.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
5.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
6 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
6.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
6.1.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
6.1.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
6.1.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
6.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
6.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
6.4 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
7 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
7.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
7.1.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
7.1.2 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
7.1.3 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
7.2 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
7.3 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
7.4 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
8 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
8.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
8.1.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
8.2 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
8.3 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
8.4 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
9 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis
9.1 Conatus Pharmaceuticals
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Daewoong Pharmaceutical
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 128 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Galmed International
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 142 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Kyorin Pharmaceutical
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Sept Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Metabolic Solutions Development
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Novartis AG
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Phenex Pharmaceuticals
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharmaceuticals Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Raptor Pharmaceuticals
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 TCM Biotech International
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 Tobira Therapeutics
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Verva Pharmaceuticals
9.12 Zafgen
10 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Maufacturing Cost Analysis
10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast (2016-2021)
14.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue Forecast (2016-2021)
14.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Regions (2016-2021)
14.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2016-2021)
14.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales of Key Manufacturers (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers (2011-2016)
Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Manufacturers (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Type (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Type (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Regions (2011-2016)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Regions (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Regions (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Application (2011-2016)
Figure USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2011-2016)
Table USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2011-2016)
Table USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2011-2016)
Table USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2011-2016)
Table USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2011-2016)
Table USA Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2011-2016)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2011-2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2011-2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2011-2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2011-2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2011-2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2011-2016)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2011-2016)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2011-2016)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2011-2016)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2011-2016)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2011-2016)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2011-2016)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2011-2016)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2011-2016)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2011-2016)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2011-2016)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2011-2016)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2011-2016)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2011-2016)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2011-2016)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2011-2016)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2011-2016)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2011-2016)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2011-2016)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2011-2016)
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Galmed International Basic Information List
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Tobira Therapeutics Basic Information List
Table Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Verva Pharmaceuticals Basic Information List
Table Verva Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Verva Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Zafgen Basic Information List
Table Zafgen Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Zafgen Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Distributors/Traders List
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2016-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Regions (2016-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2016-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2016-2021)
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 […]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining […]
  • Global Probiotics Sales Market Report 2017
    Published: 21-Apr-2017        Price: US 4000 Onwards        Pages: 117
    In this report, the global Probiotics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Probiotics for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeast ......
  • EMEA (Europe, Middle East and Africa) Sea Cucumber Capsules Market Report 2017
    Published: 21-Apr-2017        Price: US 4000 Onwards        Pages: 119
    In this report, the EMEA Sea Cucumber Capsules market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Sea Cucumber Capsules for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux......
  • EMEA (Europe, Middle East and Africa) Somatostatin Market Report 2017
    Published: 21-Apr-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the EMEA Somatostatin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Somatostatin for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Midd......
  • Global Crohn's Disease Drug Market Research Report 2017
    Published: 21-Apr-2017        Price: US 2900 Onwards        Pages: 105
    In this report, the global Crohn's Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Crohn's Disease Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Research Report 2017
    Published: 21-Apr-2017        Price: US 2800 Onwards        Pages: 197
    This report studies the Enzyme-Linked Immunosorbent Assay (ELISA) market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Enzyme-Linked Immunosorbent Assay (ELISA) market by product type and applications/end industries. The global Enzyme-Linked Immunosorbent Assay (ELISA) market is valued at 184 million USD in 2016 and is ex......
  • EMEA (Europe, Middle East and Africa) Tacrolimus Market Report 2017
    Published: 21-Apr-2017        Price: US 4000 Onwards        Pages: 126
    In this report, the EMEA Tacrolimus market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Tacrolimus for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East......
  • Global Medical Electrodes Market Research Report 2017
    Published: 21-Apr-2017        Price: US 2900 Onwards        Pages: 154
    In the last several years, global market of medical electrodes developed rapidly, with an average growth rate of 10.2%. In 2016, global revenue of medical electrodes is nearly 892.31 M USD; the actual production is about 5276.53 M units. This report studies medical electrodes in global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufact......
  • Global Anticoagulants Market Research Report 2017
    Published: 21-Apr-2017        Price: US 2900 Onwards        Pages: 104
    In this report, the global Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anticoagulants in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • North America Hard Capsule Grade Gelatin Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 21-Apr-2017        Price: US 4480 Onwards        Pages: 121
    "Gelatin is a translucent, colorless, brittle (when dry), flavorless food derived from collagen obtained from various animal raw materials such as healthy animal bone or Skin. The main raw materials of gelatin are beef bone, beef skin, fish skin or pig skin. Gelatin is commonly used as a gelling agent in food, pharmaceutical drugs, photography, and cosmetic manufacturing. In this report, we focus on pharmaceutical grade product, which is mainly used in hard capsules." Scope......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs